Literature DB >> 25355223

Direct bidirectional μ-opioid control of midbrain dopamine neurons.

Elyssa B Margolis1, Gregory O Hjelmstad2, Wakako Fujita3, Howard L Fields2.   

Abstract

The ventral tegmental area (VTA) is required for the rewarding and motivational actions of opioids and activation of dopamine neurons has been implicated in these effects. The canonical model posits that opioid activation of VTA dopamine neurons is indirect, through inhibition of GABAergic inputs. However, VTA dopamine neurons also express postsynaptic μ-opioid peptide (MOP) receptors. We report here that in Sprague Dawley rat, the MOP receptor-selective agonist DAMGO (0.5-3 μM) depolarized or increased the firing rate of 87 of 451 VTA neurons (including 22 of 110 dopamine neurons). This DAMGO excitation occurs in the presence of GABAA receptor blockade and its EC50 value is two orders of magnitude lower than for presynaptic inhibition of GABA release on to VTA neurons. Consistent with a postsynaptic channel opening, excitations were accompanied by a decrease in input resistance. Excitations were blocked by CdCl2 (100 μM, n = 5) and ω-agatoxin-IVA (100 nM, n = 3), nonselective and Cav2.1 Ca(2+) channel blockers, respectively. DAMGO also produced a postsynaptic inhibition in 233 of 451 VTA neurons, including 45 of 110 dopamine neurons. The mean reversal potential of the inhibitory current was -78 ± 7 mV and inhibitions were blocked by the K(+) channel blocker BaCl2 (100 μM, n = 7). Blockade of either excitation or inhibition unmasked the opposite effect, suggesting that MOP receptors activate concurrent postsynaptic excitatory and inhibitory processes in most VTA neurons. These results provide a novel direct mechanism for MOP receptor control of VTA dopamine neurons.
Copyright © 2014 the authors 0270-6474/14/3314707-10$15.00/0.

Entities:  

Keywords:  VTA; calcium channel; midbrain; opioid

Mesh:

Substances:

Year:  2014        PMID: 25355223      PMCID: PMC4212068          DOI: 10.1523/JNEUROSCI.2144-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  65 in total

1.  Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.

Authors:  Zafiroula Georgoussi; Leonidas Leontiadis; Georgia Mazarakou; Manolis Merkouris; Karren Hyde; Heidi Hamm
Journal:  Cell Signal       Date:  2005-08-24       Impact factor: 4.315

2.  Coexpression of delta-opioid receptors with micro receptors in GH3 cells changes the functional response to micro agonists from inhibitory to excitatory.

Authors:  Andrew C Charles; Natalya Mostovskaya; Kathleen Asas; Christopher J Evans; Megan L Dankovich; Tim G Hales
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

3.  mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding.

Authors:  A Mansour; C A Fox; R C Thompson; H Akil; S J Watson
Journal:  Brain Res       Date:  1994-04-18       Impact factor: 3.252

4.  Anatomically distinct opiate receptor fields mediate reward and physical dependence.

Authors:  M A Bozarth; R A Wise
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

5.  Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types.

Authors:  Seth M Dever; Ruqiang Xu; Sylvia Fitting; Pamela E Knapp; Kurt F Hauser
Journal:  J Neurovirol       Date:  2012-04-20       Impact factor: 2.643

6.  Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons.

Authors:  Alice Dobi; Elyssa B Margolis; Hui-Ling Wang; Brandon K Harvey; Marisela Morales
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

7.  Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: role of mu-opioid receptors.

Authors:  C Xiao; J-H Ye
Journal:  Neuroscience       Date:  2008-02-06       Impact factor: 3.590

8.  Two types of neurone in the rat ventral tegmental area and their synaptic inputs.

Authors:  S W Johnson; R A North
Journal:  J Physiol       Date:  1992-05       Impact factor: 5.182

9.  Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.

Authors:  Qin Wang; Lee-Yuan Liu-Chen; John R Traynor
Journal:  J Biol Chem       Date:  2009-05-05       Impact factor: 5.157

10.  Opioid modulation of ventral pallidal afferents to ventral tegmental area neurons.

Authors:  Gregory O Hjelmstad; Yanfang Xia; Elyssa B Margolis; Howard L Fields
Journal:  J Neurosci       Date:  2013-04-10       Impact factor: 6.167

View more
  42 in total

1.  Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry.

Authors:  Dina Popova; Nidhi Desai; Julie A Blendy; Zhiping P Pang
Journal:  J Neurosci       Date:  2019-05-20       Impact factor: 6.167

Review 2.  Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.

Authors:  Stephan Steidl; David I Wasserman; Charles D Blaha; John S Yeomans
Journal:  Neurosci Biobehav Rev       Date:  2017-09-23       Impact factor: 8.989

Review 3.  Cognitive and autonomic determinants of energy homeostasis in obesity.

Authors:  Denis Richard
Journal:  Nat Rev Endocrinol       Date:  2015-06-30       Impact factor: 43.330

Review 4.  Understanding opioid reward.

Authors:  Howard L Fields; Elyssa B Margolis
Journal:  Trends Neurosci       Date:  2015-01-29       Impact factor: 13.837

5.  The highly selective dopamine D3R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents.

Authors:  Chloe J Jordan; Bree Humburg; Myra Rice; Guo-Hua Bi; Zhi-Bing You; Anver Basha Shaik; Jianjing Cao; Alessandro Bonifazi; Alexandra Gadiano; Rana Rais; Barbara Slusher; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2019-04-08       Impact factor: 5.250

6.  Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.

Authors:  Estefanía Moreno; César Quiroz; William Rea; Ning-Sheng Cai; Josefa Mallol; Antoni Cortés; Carme Lluís; Enric I Canela; Vicent Casadó; Sergi Ferré
Journal:  J Neurosci       Date:  2016-12-22       Impact factor: 6.167

Review 7.  Opioid and hypocretin neuromodulation of ventral tegmental area neuronal subpopulations.

Authors:  Taylor S Thomas; Corey Baimel; Stephanie L Borgland
Journal:  Br J Pharmacol       Date:  2017-09-26       Impact factor: 8.739

8.  Synergy of Distinct Dopamine Projection Populations in Behavioral Reinforcement.

Authors:  Gabriel Heymann; Yong S Jo; Kathryn L Reichard; Naomi McFarland; Charles Chavkin; Richard D Palmiter; Marta E Soden; Larry S Zweifel
Journal:  Neuron       Date:  2019-12-23       Impact factor: 17.173

9.  Supplemental morphine infusion into the posterior ventral tegmentum extends the satiating effects of self-administered intravenous heroin.

Authors:  S Steidl; S Myal; R A Wise
Journal:  Pharmacol Biochem Behav       Date:  2015-04-23       Impact factor: 3.533

10.  The Aversive Agent Lithium Chloride Suppresses Phasic Dopamine Release Through Central GLP-1 Receptors.

Authors:  Samantha M Fortin; Elena H Chartoff; Mitchell F Roitman
Journal:  Neuropsychopharmacology       Date:  2015-07-27       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.